Australia’s peak body representing legal professionals has called for more support for Federal Circuit and Family Court judges following the death of Judge Guy Andrew, telling Lawyerly that the “crippling pressures and workloads” faced by judges on the chronically underfunded courts created an unsafe workplace.
The director of the besieged Mayfair investment group will submit a new noteholder proposal to the court in an effort to stave off the winding up of M101 Nominees and salvage his multi-million dollar Dunk Island and Mission Beach investments.
One of the lead applicants in a class action against ratings giant S&P Global, which is involved in a dispute with the funder that’s backing the case, wants to look at the funding agreement signed by the class action’s other lead applicant.
A court has hit Network Ten with indemnity costs after finding the broadcaster “buried” a defamation notice on its website in a manner designed to “frustrate or undermine” a settlement agreement reached with a gay American social media personality.
Pharmaceutical company Boehringer Ingelheim will take another crack at opposing a patent application for an injectable anti-parasite drug for livestock by a subsidiary of competitor Merck Sharp & Dohme.
A Sorrento bar owner backed by two high profile barristers is taking the Andrews government to the High Court claiming Victoria’s lockdown is an unconstitutional restriction on the freedom of movement of the state’s 6.6 million residents.
In a win for ASIC, a judge has found that former oil and gas company Antares Energy violated its continuous disclosure obligations by failing to reveal the name of the buyer behind an ill-fated US$254 million acquisition of Texan oil assets.
The Australian Taxation Office has secured a Full Federal Court victory in its $60 million tax battle with Healius, overturning a ruling that found the healthcare company could claw back a multi-million dollar tax refund.
The Australian Securities and Investments Commission has settled its responsible lending case against Volkswagen’s financial services unit with an undertaking from the car financier to repay customers $4.7 million.
The Federal Court has upheld Novartis’ appeal of a ruling revoking its patent for an oral form of multiple sclerosis drug Gilenya, after Australian generic drug maker Arrow Pharmaceuticals dropped its opposition to the patent despite prevailing before IP Australia.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
